Growth Metrics

Moderna (MRNA) Non-Current Debt (2025)

Moderna (MRNA) has disclosed Non-Current Debt for 1 consecutive years, with $590.0 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt changed N/A to $590.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $590.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $590.0 million for FY2025, N/A changed from the prior year.
  • Non-Current Debt for Q4 2025 was $590.0 million at Moderna.
  • The five-year high for Non-Current Debt was $590.0 million in Q4 2025, with the low at $590.0 million in Q4 2025.